ArticleJournal of experimental & clinical cancer research : CR2019

Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1.

Crescenzo D'Alterio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.